Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.
Department of Medicine, UCLA School of Medicine 90024-7050.
W C
WC
Pierce
A
A
Belldegrun
R A
RA
Figlin
D000818:Animals; D002292:Carcinoma, Renal Cell / Q000556:secondary* / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation; D008213:Lymphocyte Activation; D016246:Lymphocytes, Tumor-Infiltrating / Q000637:transplantation; D013601:T-Lymphocytes / Q000276:immunology
D007376:Interleukin-2